Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Advanced Medicine

Discovery & Development Advanced Medicine

Between the Gut and the Stars

| Rob Coker | 4 min read

CEO and Founder of EnteroBiotix James McIllroy shares the wonders of manipulating our microbial passengers.

Manufacture Advanced Medicine

Cell and Gene Champions Speak Up

| Angus Stewart

Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine

Discovery & Development Drug Delivery

Lipid Nanoparticles: From Little League to the Majors

| Bowen Tian | 8 min read

What does the future hold for lipid nanoparticles?

Discovery & Development Translational Science

From Arctic Fish To New Cell Therapy Preservation Technologies

| Maryam Mahdi | 2 min read

Cryopreservation should maintain the viability of organs and cell therapies, but the process is riddled with challenges.

Manufacture Advanced Medicine

The Nucleic Acid Revolution

| Tommy Duncan | 3 min read

Could nucleic acid medicines be the solution to the complex problems associated with advanced therapy manufacture?

Business & Regulation Business Practice

Who Are the Best Companies in the Pharma Field?

| 2 min read

Voting is now open for the 2023 Company of the Year Awards – make sure you have your say!

Manufacture Advanced Medicine

Memories From the Start of the Gene Therapy Wave

| Stephanie Sutton | 10 min read

The remarkable story of gene therapy drug development during the 1990s and early 2000s.

Manufacture Advanced Medicine

The Pros and Cons of Lentiviral and Adeno-Associated Viral Vectors

| Suparna Sanyal | 5 min read

Demand for gene therapies is rising, so all the more reason to better understand the properties of their delivery devices

Business & Regulation Standards & Regulation

Unproven Stem Cell Ruling Creates Uncertainty

| Stephanie Sutton | 2 min read

ISCT speaks out after US court rules that stem cell therapy does not fall under FDA jurisdiction.

Business & Regulation Profession

Change Is the Only Constant

| Angus Stewart | 9 min read

Diversity, support networks, and unexpected journeys: what nine years of C&G biz wisdom can teach us

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register